Advertisement

Modulation of bone turnover by Cissus quadrangularis after ovariectomy in rats

  • Juan M. Guerra
  • Martha A. Hanes
  • Cordelia Rasa
  • Nagarajan Loganathan
  • Wendy Innis-Whitehouse
  • Ednia Gutierrez
  • Saraswathy Nair
  • Jameela BanuEmail author
Original Article

Abstract

In women, age-related bone loss is associated with increased risk of bone fracture. Existing therapies are associated with severe side effects; thus, there is a need to find alternative medicines with less or optimal side effects. Cissus quadrangularis (CQ), an Ayurvedic medicine used to enhance fracture healing, was tested for its bone protective properties and studied to discern the mechanism by which it is beneficial to bone. Female Sprague Dawley rats were either sham operated or ovariectomized and were fed CQ for 3 months. Several biochemical markers, cytokines and hormones were assayed. Femur, tibia and lumbar vertebrae were subjected to pQCT and µCT densitometry. MC3T3 cells were cultured, treated with CQ and used to analyze miRNA content and subjected to qPCR for gene expression analysis related to bone metabolism. CQO rats showed protected bone mass and microarchitecture of trabecular bone in the distal femoral metaphysis and the proximal tibial metaphysis. The lumbar vertebrae, however, showed no significant changes. Serum protein expression levels of P1NP increased and Trap5b and CTX levels decreased with in vivo CQ treatment. Some influence on the anti- and pro-inflammatory markers was also observed. Significantly high level of estradiol in the CQO rats was observed. In vitro expression of a few genes related to bone metabolism showed that osteocalcin increased significantly. The other genes—collagen I expression, SPP1, BMP2, DCAT1—decreased significantly. Certain miRNA that regulate bone turnover using the BMP pathway and Wnt signaling pathways were upregulated by CQ. qPCR after acute treatment with CQ showed significantly increased levels of osteocalcin and decreased levels of Wnt/β catenin antagonist DCAT1. Overall, CQ protected the microarchitecture of the long bones from ovariectomy-induced bone loss. This may be because of decreased inflammation and modulation through the BMP and Wnt signaling pathways. We conclude that CQ is a potential therapeutic agent to treat postmenopausal osteoporosis with no side effects.

Keywords

Cissus quadrangularis Postmenopausal bone loss Static histomorphometry and bone strength Bone biochemical markers miRNA and qPCR 

Notes

Acknowledgements

We acknowledge Ms. Erika Varela, Mr. Eberto Presas for helping with the surgeries, feeding and weighing the rats regularly and Mr. Ali N Bahadur for doing some of the μCT scanning. This research did not receive any specific grant from funding agencies in the public, commercial, or non-profit sectors.

Compliance with ethical standards

Conflict of interest

The authors have no disclosures to declare.

References

  1. 1.
    McGarry KA, Kiel DP (2000) Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture. Postgrad Med 108:79–82 (85–78, 91)Google Scholar
  2. 2.
    Riggs BL, Khosla S, Melton LJ 3rd (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763–773CrossRefGoogle Scholar
  3. 3.
    Banu J, Fernandes G (2013) Animal models of menopausal metabolism. In: Martin CJH (ed) Handbook of nutrition and diet in menopause: Springer, BerlinGoogle Scholar
  4. 4.
    National Osteoporosis Foundation. Types of osteoporosis medications. http://nof.org/articles/22. Accessed 04 Jan 2016
  5. 5.
    Blick SK, Dhillon S, Keam SJ (2008) Teriparatide: a review of its use in osteoporosis. Drugs 68:2709–2737CrossRefGoogle Scholar
  6. 6.
    Rizzoli R, Reginster JY, Boonen S, Breart G, Diez-Perez A et al (2011) Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int 89:91–104CrossRefGoogle Scholar
  7. 7.
    Rubin MR, Bilezikian JP (2005) Parathyroid hormone as an anabolic skeletal therapy. Drugs 65:2481–2498CrossRefGoogle Scholar
  8. 8.
    NBJ (2000) Herbal and botanical US consumer sale 1999. California Nutr Bus J 2000:1–3Google Scholar
  9. 9.
    Bent S, Ko R (2004) Commonly used herbal medicines in the United States: a review. Am J Med 116:478–485CrossRefGoogle Scholar
  10. 10.
    Major herbs of Ayurveda (2002) In: Williamson EM (ed) Elsevier Sciences, LondonGoogle Scholar
  11. 11.
    Singh LM, Udupa KN (1962) Studies on "Cissus Quadrangularis" in fracture by using phosphorus 32 III. Indian J Med Sci 16:926–931PubMedGoogle Scholar
  12. 12.
    Udupa KN, Arnikar HJ, Singh LM (1961) Experimental studies of the use of ‘Cissus quadrangularis’ in healing of fractures II. Indian J Med Sci 15:551–557PubMedGoogle Scholar
  13. 13.
    Potu BK, Rao MS, Nampurath GK, Chamallamudi MR, Prasad K et al (2009) Evidence-based assessment of antiosteoporotic activity of petroleum-ether extract of Cissus quadrangularis Linn. on ovariectomy-induced osteoporosis. Ups J Med Sci 114:140–148Google Scholar
  14. 14.
    Potu BK, Bhat KM, Rao MS, Nampurath GK, Chamallamudi MR et al (2009) Petroleum ether extract of Cissus quadrangularis (Linn.) enhances bone marrow mesenchymal stem cell proliferation and facilitates osteoblastogenesis. Clinics (Sao Paulo) 64:993–998CrossRefGoogle Scholar
  15. 15.
    Muthusami S, Senthilkumar K, Vignesh C, Ilangovan R, Stanley J et al (2011) Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells. J Cell Biochem 112:1035–1045CrossRefGoogle Scholar
  16. 16.
    Jainu M, Devi CS (2006) Gastroprotective action of Cissus quadrangularis extract against NSAID induced gastric ulcer: role of proinflammatory cytokines and oxidative damage. Chem Biol Interact 161:262–270CrossRefGoogle Scholar
  17. 17.
    Debreczeni DE, Ruiz-Ruiz S, Aramburu J, Lopez C, Belliure B et al (2011) Detection, discrimination and absolute quantitation of Tomato spotted wilt virus isolates using real time RT-PCR with TaqMan((R))MGB probes. J Virol Methods 176:32–37CrossRefGoogle Scholar
  18. 18.
    Das K, Saikolappan S, Dhandayuthapani S (2013) Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosis. Tuberculosis (Edinb) 93(Suppl):S47–50CrossRefGoogle Scholar
  19. 19.
    Zhu Q, Hong A, Sheng N, Zhang X, Matejko A et al (2007) microParaflo biochip for nucleic acid and protein analysis. Methods Mol Biol 382:287–312CrossRefGoogle Scholar
  20. 20.
    Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P et al (2012) Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene 31:2750–2760CrossRefGoogle Scholar
  21. 21.
    Hair JFBW, Babin BJ, Anderson RE (2010) Multivariate data analysis. Prentice Hall Pearson, Upper Saddle RiverGoogle Scholar
  22. 22.
    LS TBaF (2013) Using multivariate statistics. Allyn & Bacon, BostonGoogle Scholar
  23. 23.
    Mertler CARR (2017) Advanced and multivariate statistical methods: Practical application and interpretation. Routledge, New YorkGoogle Scholar
  24. 24.
    Meyers LSGG, Guarino AJ (2017) Applied multivariate research: design and interpretation. SAGE Publications Ltd, Thousand OaksGoogle Scholar
  25. 25.
    Banu J, Varela E, Bahadur AN, Soomro R, Kazi N et al (2012) Inhibition of Bone Loss by Cissus quadrangularis in Mice: a Preliminary Report. J Osteoporos 2012:101206CrossRefGoogle Scholar
  26. 26.
    Jainu MV, K K (2010) Cissus quadrangularis L. extract attenuates chronic ulcer by possible involvement of polyamiones and proliferating cell nuclear antigen. Pharmacogn Mag 6:225–233CrossRefGoogle Scholar
  27. 27.
    Aswar UM, Mohan V, Bodhankar SL (2012) Antiosteoporotic activity of phytoestrogen-rich fraction separated from ethanol extract of aerial parts of Cissus quadrangularis in ovariectomized rats. Indian J Pharmacol 44:345–350CrossRefGoogle Scholar
  28. 28.
    Nagani KV, Kevalia J, Chandra SV (2011) Pharmacological and phytochemical evaluation of stem of Cissus quadrangualris L. Int J Pharm Sc Res 2:2856–2862Google Scholar
  29. 29.
    Austin A. K, R., Jegadeesan M. (2004) Pharmacological Studies on Cissus quadrangualris L Variant I and II. Anc Sci Life XXIII: 33–47.Google Scholar
  30. 30.
    Udayakumar R, Sundaran M, Krishna R (2004) Mineral and biochemical analysis of various parts of Cissus quadrangularis linn. Anc Sci Life 24:79–82PubMedPubMedCentralGoogle Scholar
  31. 31.
    Srivastava AK, Srivasta P, Behera BR, Shrivastava AK (2011) Pharmacological and Phyto-chemical Investigation of Cissus quadrangularis Linn Stem. Int J Pharn Res Dev 3:207–215Google Scholar
  32. 32.
    Gupta MMAVRK (1990) Lipid constituents of Cissus quadrangularis. Phytochemistry 30:875–878CrossRefGoogle Scholar
  33. 33.
    Adesanya SA, Nia R, Martin M-T, Boukamcha N, Montagnac A, Pais M (1999) Stilbene derivatives for Cissus quadrangularis. J Nat Prod 62:1694CrossRefGoogle Scholar
  34. 34.
    Singh G, Rawat P, Maurya R (2007) Constituents of Cissus quadrangularis. Nat Prod Res 21:522–528CrossRefGoogle Scholar
  35. 35.
    Bhutani KK, Kapoor R, Atal CK (1984) Two unsymmettric tetracyclic triterpenoids from Cissus quadrangualris. Phytochemistry 23:407–410CrossRefGoogle Scholar
  36. 36.
    Sharma U, Pal D, Prasad R (2014) Alkaline phosphatase: an overview. Indian J Clin Biochem 29:269–278CrossRefGoogle Scholar
  37. 37.
    Fratzl P, Paris O, Klaushofer K, Landis WJ (1996) Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle X-ray scattering. J Clin Invest 97:396–402CrossRefGoogle Scholar
  38. 38.
    Hauschka PV, Wians Jr FH (1989) Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec 224:180–188Google Scholar
  39. 39.
    Lombardi G, Perego S, Luzi L, Banfi G (2015) A four-season molecule: osteocalcin Updates in its physiological roles. Endocrine 48:394–404CrossRefGoogle Scholar
  40. 40.
    Wei J, Karsenty G (2015) An overview of the metabolic functions of osteocalcin. Curr Osteoporos Rep 13:180–185CrossRefGoogle Scholar
  41. 41.
    Montero M, Diaz-Curiel M, Guede D, Caeiro JR, Martin-Fernandez M et al (2012) Effects of kalsis, a dietary supplement, on bone metabolism in the ovariectomized rats. J Osteoporos 2012:639427CrossRefGoogle Scholar
  42. 42.
    Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65:S147–S151CrossRefGoogle Scholar
  43. 43.
    Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E et al (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297–3303PubMedGoogle Scholar
  44. 44.
    Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC et al (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88–91CrossRefGoogle Scholar
  45. 45.
    Poli V, Balena R, Fattori E, Markatos A, Yamamoto M et al (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189–1196CrossRefGoogle Scholar
  46. 46.
    Boyle RA, Lenton TM (2006) Fluctuation in the physical environment as a mechanism for reinforcing evolutionary transitions. J Theor Biol 242:832–843CrossRefGoogle Scholar
  47. 47.
    Panthong A, Supraditaporn W, Kanjanapothi D, Taesotikul T, Reutrakul V (2007) Analgesic, anti-inflammatory and venotonic effects of Cissus quadrangularis Linn. J Ethnopharmacol 110:264–270CrossRefGoogle Scholar
  48. 48.
    Bhujade AM, Talmale S, Kumar N, Gupta G, Reddanna P et al (2012) Evaluation of Cissus quadrangularis extracts as an inhibitor of COX, 5-LOX, and proinflammatory mediators. J Ethnopharmacol 141:989–996CrossRefGoogle Scholar
  49. 49.
    Aswar UM, Bhaskaran S, Mohan V, Bodhankar SL (2010) Estrogenic activity of friedelin rich fraction (IND-HE) separated from Cissus quadrangularis and its effect on female sexual function. Pharmacognosy Res 2:138–145CrossRefGoogle Scholar
  50. 50.
    Grady D, Rubin SM, Petitti DB, Fox CS, Black D et al (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016–1037CrossRefGoogle Scholar
  51. 51.
    Quigley MTM, Burnier PL, P AM (1987) Estrogen therapy arrests bone loss in elderly women. Am J Ob Gyn 156:1516–1523CrossRefGoogle Scholar
  52. 52.
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321–333CrossRefGoogle Scholar
  53. 53.
    Torgerson DJ, Bell-Syer SE (2001) Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 285:2891–2897CrossRefGoogle Scholar
  54. 54.
    Casabiell X, Pineiro V, Peino R, Lage M, Camina J et al (1998) Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 83:2149–2155PubMedGoogle Scholar
  55. 55.
    Chu SC, Chou YC, Liu JY, Chen CH, Shyu JC et al (1999) Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci 64:2299–2306CrossRefGoogle Scholar
  56. 56.
    Hauser G, Hauser R (1981) Infant botulism—a "New" disease. Harefuah 100:438–440PubMedGoogle Scholar
  57. 57.
    Gimble JM, Nuttall ME (2012) The relationship between adipose tissue and bone metabolism. Clin Biochem 45:874–879CrossRefGoogle Scholar
  58. 58.
    Combs TP, Marliss EB (2014) Adiponectin signaling in the liver. Rev Endocr Metab Disord 15:137–147CrossRefGoogle Scholar
  59. 59.
    Naot D, Musson DS, Cornish J (2017) The activity of adiponectin in bone. Calcif Tissue Int 100:486–499CrossRefGoogle Scholar
  60. 60.
    Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S et al (2009) Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 160:265–273CrossRefGoogle Scholar
  61. 61.
    Araneta MR, von Muhlen D, Barrett-Connor E (2009) Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res 24:2016–2022CrossRefGoogle Scholar
  62. 62.
    Abbott MJ, Roth TM, Ho L, Wang L, O'Carroll D et al (2015) Negative skeletal effects of locally produced adiponectin. PLoS One 10:e0134290CrossRefGoogle Scholar
  63. 63.
    Cheyette BN, Waxman JS, Miller JR, Takemaru K, Sheldahl LC et al (2002) Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell 2:449–461CrossRefGoogle Scholar
  64. 64.
    Zhang L, Gao X, Wen J, Ning Y, Chen YG (2006) Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J Biol Chem 281:8607–8612CrossRefGoogle Scholar
  65. 65.
    Kothari SC, Shivarudraiah P, Venkataramaiah SB, Koppolu KP, Gavara S et al (2011) Safety assessment of Cissus quadrangularis extract (CQR-300): subchronic toxicity and mutagenicity studies. Food Chem Toxicol 49:3343–3357CrossRefGoogle Scholar
  66. 66.
    Stohs SJ, Ray SD (2013) A review and evaluation of the efficacy and safety of Cissus quadrangularis extracts. Phytother Res 27:1107–1114CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  • Juan M. Guerra
    • 1
    • 2
  • Martha A. Hanes
    • 3
  • Cordelia Rasa
    • 4
  • Nagarajan Loganathan
    • 5
  • Wendy Innis-Whitehouse
    • 6
  • Ednia Gutierrez
    • 1
  • Saraswathy Nair
    • 1
  • Jameela Banu
    • 1
    • 2
    Email author
  1. 1.Department of Health and Biomedical SciencesUniversity of Texas Rio Grande ValleyEdinburgUSA
  2. 2.Department of BiologyUniversity of Texas Rio Grande ValleyEdinburgUSA
  3. 3.Department of Lab Animal ResourcesUniversity of Texas Health at San AntonioSan AntonioUSA
  4. 4.Department of Lab Animal ResourcesUniversity of Texas Rio Grande ValleyEdinburgUSA
  5. 5.Poorveegam Research TrustPondicherryIndia
  6. 6.School of MedicineUniversity of Texas Rio Grande ValleyEdinburgUSA

Personalised recommendations